Five Strategies To Boost Clinical Trial Diversity
Without taking specific steps to improve trial diversity, advances in inclusive treatments will continue at a snail’s pace.
Mitesh B. Rao, MD, MHS</a> is the Assistant Professor of Emergency Medicine at Stanford and the CEO and co-founder of <a href=https://medcitynews.com/author/mbrao/"https://omnyhealth.com/">OMNY Health</a>, a venture-backed enterprise fostering real-world data collaboration between providers and Life Sciences companies to accelerate clinical research." />
Without taking specific steps to improve trial diversity, advances in inclusive treatments will continue at a snail’s pace.